Medical Information Online
Navigate to BMS
Home
Prescribing Information
Submit Medical Inquiry
Contact Us

Prescribing Information

Find prescribing information about our medicines by clicking on any of the products or Regimen below.

Products
ABECMA® (idecabtagene vicleucel) ABRAXANE® (paclitaxel protein-bound particles) BARACLUDE® (entecavir) BREYANZI® (lisocabtagene maraleucel) CAMZYOS® (mavacamten) ELIQUIS® (apixaban) EMPLICITI® (elotuzumab) EVOTAZ® (atazanavir and cobicistat) IDHIFA® (enasidenib) INREBIC® (fedratinib) ISTODAX® (romidepsin) NULOJIX® (belatacept) ONUREG® (azacitadine tablets) OPDIVO® (nivolumab) OPDUALAG® (relatlimab and nivolumab) ORENCIA® (abatacept) POMALYST® (pomalidomide) REBLOZYL® (luspatercept-aamt) REVLIMID® (lenalidomide) REYATAZ® (atazanavir) SPRYCEL® (dasatinib) SUSTIVA® (efavirenz) THALOMID® (thalidomide) VIDAZA® (azacitidine) YERVOY® (ipilimumab) ZEPOSIA® (ozanimod)
Regimen
OPDIVO® (nivolumab) + YERVOY® (ipilimumab) Regimen

ABECMA, ABRAXANE, BARACLUDE, BREYANZI, CAMZYOS,  DAKLINZA, ELIQUIS, EMPLICITI, EVOTAZ, IDHIFA, INREBIC, ISTODAX, NULOJIX, ONUREG, OPDIVO, OPDUALAG, ORENCIA, POMALYST, REBLOZYL, REVLIMID, REYATAZ, SPRYCEL, SUSTIVA, THALOMID, VIDAZA, YERVOY, ZEPOSIA are trademarks of Bristol-Myers Squibb Company.

Medical Information Online

Assisting U.S. healthcare providers in caring for patients and conducting research with BMS medicines.

BMS Medical  >

Your use of this information is subject to the terms and conditions of our Legal Notice and Privacy Policy. This site is intended for healthcare professionals and is for informational purposes only.

Medical Information Contact Center
877-417-1523 (toll free U.S. only)

Mon - Fri, 8 am - 8pm ET

Report Adverse Events or Product Quality Complaints
800-721-5072 (toll free U.S. only)

For outside the U.S., visit our global site to report Adverse Events, Product Quality Complaints or submit a Medical Information inquiry.

Follow us
Legal Notice
Privacy Policy
Trademark
Worldwide Medical Information Portal
© 2022 Bristol-Myers Squibb Company
CV-US-2200268 05/2022